Impact of Web Application Support Versus Standard Management on Compliance With Adjuvant Hormone Therapy at 18 Months in Patients Treated for Breast Cancer

Impact of Web Application Support Versus Standard Management on Compliance With Adjuvant Hormone Therapy at 18 Months in Patients Treated for Breast Cancer

The investigators hypothesize that the implementation of a Web-application in patients initiating adjuvant hormone therapy for breast cancer brings a benefit on treatment adherence and quality of life.

Inclusion Criteria:

• Patient > 18 years old
• Breast cancer patient candidate for adjuvant hormone therapy
• Mastery of the French language
• Patient with a cell phone and an Internet connection
• Patient able to use a computer, smartphone, or tablet.
• Patient affiliated to a social security system
• Signing of informed consent prior to any specific study-related procedure

Exclusion Criteria:

• Patient who has previously received hormone therapy for cancer.
• Patient not trained in the use of the application
• Any associated medical or psychiatric condition that might compromise the patient's ability to participate in the study
• Patients with locoregional or metastatic recurrence
• Other history of cancer.
• Patient deprived of liberty, under guardianship or curatorship
• Simultaneous participation in a therapeutic clinical trial or other clinical study involving a connected tool
• Patient unable to undergo trial follow-up for geographical, social or psychopathological reasons